Delivery Order SPE2DB24D1104-SPE2DB24FYAD3

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a ceiling value of $6,005.90 and a performance period through February 2, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,018.27, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,719.71, is a delivery order for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563062398 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a ceiling value of $43,999.35 and an ultimate completion date of December 12, 2023. It is a Firm Fixed Price contract, with no set-aside designation indicated....
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566584139 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a ceiling value of $6,574.73. The contract has an ultimate completion date of December 3, 2024. This award is a delivery order contract, with a firm fixed price pricing type. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, with a ceiling value of $2,658.94 and a performance period through May 2, 2025. The contract is not set aside and is awarded as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp, a for-profit corporate...
This federal contract award, valued at $7,824.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a completion date of December 18, 2023. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside requirement. Amerisourcebergen Drug Corp holds a significant...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,132.14, is for the procurement of 230 ml bottles of NITROFURANTOIN 25 MG/5 ML SUSP medication. The contract has an ultimate completion date of November 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $3,414.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product NITROFURANTOIN 25 MG/5 ML SUSP 240ML. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor providing a wide range of...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAD3
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,575.16, is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a period of performance ending on July 10, 2024 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. The DLA is the funding agency, and this contract supports the agency's medical supply procurement for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/17/25, 9:45 AM